The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: A 10 year survey

Nephrology Dialysis Transplantation

Volumn 19, Issue 7, 2004, Pages 1829-1834

  Paoletti, Ernesto ^a,b   Specchia, Claudia ^a,b   Di Maio, Giovanni ^a,b   Bellino, Diego ^a,b   Damasio, Beatrice ^a,b   Cassottana, Paolo ^a,b   Cannella, Giuseppe ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Haemodialysis; Left ventricular hypertrophy; Sudden cardiac death

Indexed keywords

ATENOLOL; CALCITRIOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE; PHOSPHATE BINDING AGENT; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BODY SURFACE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEALTH SURVEY; HEART DEATH; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SUDDEN DEATH;

ADULT; AGED; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 3242666899     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh288     Document Type: Article

References (34)

1. US Renal Data System. USRDS 2001 Annual Data Report, Bethesda, MO, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001.
2. van Dijk PCW, Jager KJ, de Charro F et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001; 16: 1120-1129.
3. Becker LB, Smith DW, Rhodes KV. Incidence of cardiac arrest: a neglected factor in evaluating survival rates. Ann Emerg Med 1993; 22: 86-91.
4. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function and time-dependance of risk. Circulation 1992; 85 [Suppl]: I2-I10.
5. Herzog CA. Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int 2003; 63 [Suppl 84]: S197-S200.
6. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999; 55: 1553-1559.
7. Karnik JA, Young BS, Lew NL et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001; 60: 350-357.
8. Cannella G, Paoletti E, Delfino R, Peloso GC, Molinari S, Traverso GB. Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 1993; 44: 881-886.
9. Cannella G, Paoletti E, Delfino R, Peloso GC, Rolla D, Molinari S. Prolonged therapy with ACE inhibitors induces a regression of left ventriculir hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis 1997; 30: 659-664.
10. Sargent JA, Gotch FA. Mathematic modeling of dialysis therapy. Kidney Int 1980; 18 [Suppl 10]: S2-S11.
11. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necroscopy findings. Am J Cardiol 1986; 57: 450-458.
12. Ganau A, Saba PG, Roman MJ, de Simone G, Realdi G, Devereux RB. Ageing induces left ventricular concentric remodelling in normotensive subjects. J Hypertens 1995; 13: 1818-1822.
13. Longenecker JC, Coresh J, Klag MJ et al. validation of comorbid conditions on the End-Stage Renal disease Medical Evidence Report: The CHOICE Study. J Am Soc Nephrol 2000; 11: 520-529.
14. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998; 32: 1454-1459.
15. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286-290.
16. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 1998; 54: 1720-1725.
17. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001; 345: 1473-1482.
18. Marcus ML, Koyanagi S, Harrison DG, Doty DB, Hiratzka LF, Eastham CL. Abnormalities in the coronary circulation that occurs as a consequence of cardiac hypertrophy. Am J Med 1983; 75 [Suppl 3A]: 62-66.
19. Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED. Hypertension and suddden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984; 77: 18-22.
20. Ritz E, Rambausek M, Mall G, Ruffmann K, Mandelbaum A. Cardiac changes in uremia and their possible relationship to cardiovascular instability on dialysis. Nephrol Dial Transplant 1990; 5 [Suppl 19]: 93-97.
21. Maggioni AP, Zuanetti G, Franzosi MG et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation 1993; 87: 312-322.
22. Teerlink JR, Jalaluddin M, Anderson S et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation 2000; 101: 40-46.
23. Hayano J, Takahashi H, Toriyama T et al. Prognostic value of heart rate variability during long-term follow-up in chronic hemodialysis patients with end-stage renal disease. Nephrol Dial Transplant 1999; 14: 1480-1488.
24. Beaubien ER, Pylypchuk GB, Akhtar J, Biem HJ. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis 2002; 39: 834-842.
25. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379-1385.
26. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: the Framingham Heart Study. Ann Intern Med 1988; 108: 7-13.
27. Cannella G, Paoletti E, Ravera G et al. Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients. Kidney Int 2000; 58: 260-268.
28. Paoletti E, Cannella G. Arterial hypertension and left ventricular hypertrophy in hemodialysis patients. Clin Nephrol 2002; 58 [Suppl 1]: S46-S51.
29. McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987; 317: 787-792.
30. Wannamethee G, Shaper AG, Macfarlane PW, Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation 1995; 91: 1749-1756.
31. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61.
32. Paoletti E, Cassottana P, Bellino D, Specchia C, Messa PG, Cannella G. Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. Am J Kidney Dis 2002; 40: 728-736.
33. London GM, Pannier B, Guerin AP et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001; 12: 2759-2767.
34. Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM. Prospective study of C-reactive protein, homocysteine and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002; 105: 2595-2599.